• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双膦酸盐相关性颌骨坏死:英国与国际双膦酸盐相关性颌骨坏死管理政策的文献综述

Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw.

作者信息

McLeod Niall M H, Patel Vinod, Kusanale Atul, Rogers Simon N, Brennan Peter A

机构信息

Oral & Maxillofacial Surgery Department, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY, UK.

出版信息

Br J Oral Maxillofac Surg. 2011 Jul;49(5):335-42. doi: 10.1016/j.bjoms.2010.08.005. Epub 2010 Sep 22.

DOI:10.1016/j.bjoms.2010.08.005
PMID:20863603
Abstract

Despite the increasing number of cases of osteonecrosis of the jaws related to bisphosphonate therapy described in the literature there is a paucity of evidence-based treatment for the condition. In this second article on bisphosphonate-related jaw complications we discuss the different treatment strategies for the condition, review current literature, particularly in relation to the recommendations that have been published, and discuss the evidence behind them.

摘要

尽管文献中描述的与双膦酸盐治疗相关的颌骨坏死病例数量不断增加,但针对该病症的循证治疗却很匮乏。在这篇关于双膦酸盐相关颌骨并发症的第二篇文章中,我们讨论了针对该病症的不同治疗策略,回顾了当前的文献,特别是与已发表的建议相关的文献,并讨论了这些建议背后的证据。

相似文献

1
Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw.双膦酸盐相关性颌骨坏死:英国与国际双膦酸盐相关性颌骨坏死管理政策的文献综述
Br J Oral Maxillofac Surg. 2011 Jul;49(5):335-42. doi: 10.1016/j.bjoms.2010.08.005. Epub 2010 Sep 22.
2
Bisphosphonate osteonecrosis of the jaw--a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention.双膦酸盐相关性颌骨坏死——关于英国双膦酸盐政策与国际政策、风险因素及预防的文献综述
Br J Oral Maxillofac Surg. 2011 Jun;49(4):251-7. doi: 10.1016/j.bjoms.2010.05.007. Epub 2010 Jun 7.
3
Osteonecrosis of the jaws in intravenous bisphosphonate use: Proposal for a modification of the clinical classification.静脉注射双膦酸盐类药物所致颌骨骨坏死:临床分类修订建议
Oral Oncol. 2009 Jul;45(7):645-6. doi: 10.1016/j.oraloncology.2008.05.011. Epub 2008 Aug 19.
4
Biophosphonate-related osteonecrosis of the jaws.双膦酸盐相关颌骨骨坏死
Dent Clin North Am. 2008 Jan;52(1):111-28, ix. doi: 10.1016/j.cden.2007.09.002.
5
Bisphosphonate-related osteonecrosis of the jaw.双膦酸盐相关颌骨坏死
SADJ. 2011 Feb;66(1):30-2.
6
Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.加拿大双膦酸盐相关颌骨坏死共识实践指南。
J Rheumatol. 2008 Jul;35(7):1391-7. Epub 2008 Jun 1.
7
Treatment protocols of bisphosphonate-related osteonecrosis of the jaws.双膦酸盐相关颌骨坏死的治疗方案。
Head Neck. 2009 Aug;31(8):1112-3; author reply 1113-4. doi: 10.1002/hed.21148.
8
A review of bisphosphonate-associated osteonecrosis of the jaws and its management.双膦酸盐相关颌骨坏死及其处理的综述
J Can Dent Assoc. 2007 Jun;73(5):417-22.
9
[Bisphosphonate-induced osteonecrosis of the jaws--a guide to diagnosis, therapy and prevention of BON in dental practice].[双膦酸盐类药物所致颌骨坏死——牙科实践中颌骨坏死的诊断、治疗及预防指南]
Schweiz Monatsschr Zahnmed. 2008;118(2):113-23.
10
Bisphosphonate-related osteochemonecrosis of the jaws.双膦酸盐相关的颌骨骨坏死
Br J Hosp Med (Lond). 2008 Mar;69(3):158-62. doi: 10.12968/hmed.2008.69.3.28753.

引用本文的文献

1
Low-Level Laser Therapy in the Management of Bisphosphonate-Related Osteonecrosis of the Jaw.低强度激光疗法在双膦酸盐相关颌骨坏死治疗中的应用
J Clin Med. 2025 Jun 23;14(13):4441. doi: 10.3390/jcm14134441.
2
[Therapeutic alternatives for drug-associated maxillary osteonecrosis (MRONJ): reports of two clinical cases and review of the literature].[药物相关性上颌骨坏死(MRONJ)的治疗选择:两例临床病例报告及文献综述]
Rev Fac Cien Med Univ Nac Cordoba. 2022 Dec 21;79(4):379-382. doi: 10.31053/1853.0605.v79.n4.37289.
3
Medication-related osteonecrosis of the jaw: An update.
药物相关性颌骨坏死:最新进展
Natl J Maxillofac Surg. 2022 Jan-Apr;13(1):5-10. doi: 10.4103/njms.NJMS_236_20. Epub 2022 Apr 20.
4
CD34 and CD105 Microvessels in Resected Bone Specimen May Implicate Wound Healing in MRONJ.切除骨标本中的 CD34 和 CD105 微血管可能与 MRONJ 中的伤口愈合有关。
Int J Environ Res Public Health. 2021 Oct 29;18(21):11362. doi: 10.3390/ijerph182111362.
5
Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw.药物相关性颌骨骨坏死的发病机制与多学科管理。
Int J Oral Sci. 2020 Oct 21;12(1):30. doi: 10.1038/s41368-020-00093-2.
6
Evaluation of the effect of teriparatide therapy on mandibular fracture healing in rats with medication-related osteonecrosis of the jaw.评价特立帕肽治疗药物相关性颌骨骨坏死大鼠下颌骨骨折愈合的效果。
Clin Oral Investig. 2019 Nov;23(11):3987-3993. doi: 10.1007/s00784-019-02830-2. Epub 2019 Feb 4.
7
Osteonecrosis of the jaw induced by receptor activator of nuclear factor-kappa B ligand (Denosumab) - Review.核因子κB受体活化因子配体(地诺单抗)诱导的颌骨坏死——综述
Med Oral Patol Oral Cir Bucal. 2016 Jul 1;21(4):e431-9. doi: 10.4317/medoral.21044.
8
Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.双膦酸盐相关颌骨骨坏死的外科治疗:文献综述
Oral Maxillofac Surg. 2016 Mar;20(1):9-17. doi: 10.1007/s10006-015-0538-x. Epub 2015 Dec 11.
9
Osteoradionecrosis of the Jaws: Clinico-Therapeutic Management: A Literature Review and Update.颌骨放射性骨坏死:临床治疗管理:文献综述与更新
J Maxillofac Oral Surg. 2015 Dec;14(4):891-901. doi: 10.1007/s12663-015-0762-9. Epub 2015 Mar 10.
10
Genetic investigation of bisphosphonate-related osteonecrosis of jaw (BRONJ) via whole exome sequencing and bioinformatics.通过全外显子组测序和生物信息学对双膦酸盐相关颌骨坏死(BRONJ)进行遗传学研究。
PLoS One. 2015 Feb 10;10(2):e0118084. doi: 10.1371/journal.pone.0118084. eCollection 2015.